Implications of high level pseudogene transcription in Mycobacterium leprae.
BACKGROUND
The Mycobacterium leprae genome has less than 50% coding capacity and 1,133 pseudogenes. Preliminary evidence suggests that some pseudogenes are expressed. Therefore, defining pseudogene transcriptional and translational potentials of this genome should increase our understanding of their impact on M. leprae physiology.


RESULTS
Gene expression analysis identified transcripts from 49% of all M. leprae genes including 57% of all ORFs and 43% of all pseudogenes in the genome. Transcribed pseudogenes were randomly distributed throughout the chromosome. Factors resulting in pseudogene transcription included: 1) co-orientation of transcribed pseudogenes with transcribed ORFs within or exclusive of operon-like structures; 2) the paucity of intrinsic stem-loop transcriptional terminators between transcribed ORFs and downstream pseudogenes; and 3) predicted pseudogene promoters. Mechanisms for translational "silencing" of pseudogene transcripts included the lack of both translational start codons and strong Shine-Dalgarno (SD) sequences. Transcribed pseudogenes also contained multiple "in-frame" stop codons and high Ka/Ks ratios, compared to that of homologs in M. tuberculosis and ORFs in M. leprae. A pseudogene transcript containing an active promoter, strong SD site, a start codon, but containing two in frame stop codons yielded a protein product when expressed in E. coli.


CONCLUSIONS
Approximately half of M. leprae's transcriptome consists of inactive gene products consuming energy and resources without potential benefit to M. leprae. Presently it is unclear what additional detrimental affect(s) this large number of inactive mRNAs has on the functional capability of this organism. Translation of these pseudogenes may play an important role in overall energy consumption and resultant pathophysiological characteristics of M. leprae. However, this study also demonstrated that multiple translational "silencing" mechanisms are present, reducing additional energy and resource expenditure required for protein production from the vast majority of these transcripts.
Williams
Diana L
DL
HRSA, BPHC, Division of National Hansen's Disease Programs, Laboratory Research Branch, Molecular Biology Research Department, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, USA. dwill21@lsu.edu
Slayden
Richard A
RA
Amin
Amol
A
Martinez
Alejandra N
AN
Pittman
Tana L
TL
Mira
Alex
A
Mitra
Anirban
A
Nagaraja
Valakunja
V
Morrison
Norman E
NE
Moraes
Milton
M
Gillis
Thomas P
TP
D001483:Base Sequence; D018387:Codon, Initiator; D018388:Codon, Terminator; D020869:Gene Expression Profiling; D015964:Gene Expression Regulation, Bacterial; D020868:Gene Silencing; D005798:Genes, Bacterial; D016680:Genome, Bacterial; D008969:Molecular Sequence Data; D009166:Mycobacterium leprae / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis; D016366:Open Reading Frames; D011401:Promoter Regions, Genetic; D014176:Protein Biosynthesis; D011544:Pseudogenes; D014158:Transcription, Genetic
D018387:Codon, Initiator; D018388:Codon, Terminator
Biotechniques. 2003 Sep;35(3):534-6, 538, 540-1
14513559
Genome Biol. 2004;5(9):R64
15345048
Int J Lepr Other Mycobact Dis. 2001 Mar;69(1):1-12
11480310
Trends Biochem Sci. 1998 Sep;23(9):341-7
9787640
Nucleic Acids Res. 2004 Jun 30;32(11):3503-10
15229294
Trends Genet. 2002 Jun;18(6):291-4
12044357
J Infect Dis. 2002 Nov 1;186(9):1283-96
12402198
J Mol Microbiol Biotechnol. 2004;8(1):58-72
15741741
J Bacteriol. 1999 Jan;181(2):469-76
9882660
Nucleic Acids Res. 2002 Feb 1;30(3):675-84
11809879
Mol Biol Evol. 1993 Mar;10(2):271-81
8487630
FEMS Microbiol Lett. 2006 Jun;259(2):208-14
16734781
Mol Biol Evol. 2005 Nov;22(11):2135-8
16014873
Bioinformatics. 1999 Jul-Aug;15(7-8):578-81
10487865
Genome Biol. 2001;2(12):RESEARCH0054
11790257
Trends Genet. 2002 Jul;18(7):331-4
12127764
Genome Res. 2006 Feb;16(2):149-56
16365377
Nucleic Acids Res. 2001 Jan 1;29(1):264-7
11125107
Genome Res. 2007 Aug;17(8):1178-85
17623808
Mol Biol Evol. 1999 Sep;16(9):1178-91
10486973
J Biol Chem. 1996 Sep 6;271(36):21803-7
8702978
Trends Microbiol. 2003 Feb;11(2):59-61
12598124
Nucleic Acids Res. 2005 Jun 02;33(10):3125-32
15933207
J Mol Evol. 1993 Jan;36(1):96-9
8433381
Nucleic Acids Res. 1994 Dec 11;22(24):5497-503
7816643
Nature. 2001 Feb 22;409(6823):1007-11
11234002
Lepr Rev. 2001 Dec;72(4):387-98
11826475
Genome Biol. 2004;5(4):R27
15059260
Nature. 1998 Jun 11;393(6685):537-44
9634230
J Med Microbiol. 2005 Mar;54(Pt 3):259-268
15713609
Nature. 2003 May 1;423(6935):91-6
12721631
BMC Microbiol. 2005 Oct 04;5:56
16202144
Mol Microbiol. 2003 Jun;48(6):1491-500
12791133
Genome Res. 2004 Nov;14(11):2273-8
15479949
Genome Res. 2007 Feb;17(2):192-200
17210928
J Bacteriol. 2007 Dec;189(24):8818-27
17933896
J Clin Microbiol. 2006 Apr;44(4):1502-8
16597883
Cold Spring Harb Symp Quant Biol. 1987;52:123-33
2456874
Trends Ecol Evol. 2000 Aug;15(8):321-326
10884696
EMBO J. 1995 Apr 18;14(8):1812-8
7737131
Trends Microbiol. 2006 May;14(5):200-6
16569502
Proteomics. 2008 Jun;8(12):2477-91
18563741
J Biol Chem. 2001 Nov 9;276(45):41850-5
11551936
Proteomics. 2004 Oct;4(10):2942-53
15378742
EMBO J. 1999 Aug 16;18(16):4464-75
10449412
Microbiology (Reading). 2004 Jan;150(Pt 1):4-7
14702392